Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]

This article refers to:

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management

Al-Janabi A, Yiu ZZN. Psoriasis (Auckl). 2022;12:1–14.

The authors have advised that there is an error in Table 1 on page 2. The text “IL-7A” in the Target column for the Ixekizumab row should read “IL-17A”.

The authors apologize for this error.